Literature DB >> 15181016

Connexin43 interacts with NOV: a possible mechanism for negative regulation of cell growth in choriocarcinoma cells.

Alexandra Gellhaus1, Xuesen Dong, Sven Propson, Karen Maass, Ludger Klein-Hitpass, Mark Kibschull, Otto Traub, Klaus Willecke, Bernard Perbal, Stephen J Lye, Elke Winterhager.   

Abstract

The gap junction protein connexin43 (Cx43) is thought to be involved in growth control in several tissues. Using the doxycycline inducible tet-on system, we generated human malignant trophoblast Jeg3 cells transfected with either Cx40, Cx43, or C-terminal truncated Cx43 (trCx43). Cx43, but not Cx40 or trCx43, displayed a reduced cell growth of Jeg3 cells in vitro and tumor growth in nude mice, suggesting a role of the C terminus of Cx43 in growth regulation. Using gene array analysis, the growth regulator NOV (CCN3), a member of the CCN gene family, was found to be up-regulated only in the Cx43-transfected cells. Validation by reverse transcriptase-PCR confirmed an up-regulation of the NOV transcript exclusively upon Cx43 induction. In contrast to Cx40 or trCx43, induction of Cx43 led to a switch in localization of NOV from the nucleus to the cell membrane, where it is colocalized with Cx43. Coimmunoprecipitation showed a binding of NOV to the C terminus of Cx43 in vitro as well as in transfected cells. Jeg3 cells transfected only with NOV revealed that NOV itself acts as a growth regulator. We suggest that Cx43 is able to regulate cell growth via an up-regulation of NOV transcription, a change in localization of the NOV protein and a binding of NOV to the C terminus of Cx43.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15181016     DOI: 10.1074/jbc.M404073200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

Review 1.  Lymphatic communication: connexin junction, what's your function?

Authors:  J D Kanady; A M Simon
Journal:  Lymphology       Date:  2011-09       Impact factor: 1.286

Review 2.  Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets.

Authors:  Joon-Il Jun; Lester F Lau
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694

3.  Expression of CCN3 protein in human Wilms' tumors: immunohistochemical detection of CCN3 variants using domain-specific antibodies.

Authors:  Manish Mani Subramaniam; Noureddine Lazar; Samuel Navarro; Bernard Perbal; Antonio Llombart-Bosch
Journal:  Virchows Arch       Date:  2007-12-08       Impact factor: 4.064

Review 4.  Life cycle of connexins in health and disease.

Authors:  Dale W Laird
Journal:  Biochem J       Date:  2006-03-15       Impact factor: 3.857

5.  Organizational principles of the connexin-related brain transcriptome.

Authors:  David C Spray; Dumitru A Iacobas
Journal:  J Membr Biol       Date:  2007-07-27       Impact factor: 1.843

Review 6.  Gap junctions.

Authors:  Morten Schak Nielsen; Lene Nygaard Axelsen; Paul L Sorgen; Vandana Verma; Mario Delmar; Niels-Henrik Holstein-Rathlou
Journal:  Compr Physiol       Date:  2012-07       Impact factor: 9.090

Review 7.  Physiological roles of connexins and pannexins in reproductive organs.

Authors:  Mark Kibschull; Alexandra Gellhaus; Diane Carette; Dominique Segretain; Georges Pointis; Jerome Gilleron
Journal:  Cell Mol Life Sci       Date:  2015-06-23       Impact factor: 9.261

Review 8.  Connexins, pannexins, innexins: novel roles of "hemi-channels".

Authors:  Eliana Scemes; David C Spray; Paolo Meda
Journal:  Pflugers Arch       Date:  2008-10-14       Impact factor: 3.657

9.  Nephroblastoma overexpressed (Nov) inactivation sensitizes osteoblasts to bone morphogenetic protein-2, but nov is dispensable for skeletal homeostasis.

Authors:  Ernesto Canalis; Anna Smerdel-Ramoya; Deena Durant; Aris N Economides; Wesley G Beamer; Stefano Zanotti
Journal:  Endocrinology       Date:  2009-11-24       Impact factor: 4.736

10.  Report on the fifth international workshop on the CCN family of genes.

Authors:  A E Irvine; B Perbal; H Yeger
Journal:  J Cell Commun Signal       Date:  2009-01-21       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.